-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Fulcrum Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
- Fulcrum Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.89 USD/shares.
- Fulcrum Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.34 USD/shares, a 80.7% increase year-over-year.
- Fulcrum Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.59 USD/shares, a 34.8% increase from 2022.
- Fulcrum Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.44 USD/shares, a 6.55% decline from 2021.
- Fulcrum Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -2.29 USD/shares, a 17.9% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)